# Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients

> **NCT01308944** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 24 (actual)

## Conditions studied

- Invasive Epithelial Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Cancer

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT01308944
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-08
- **Final completion:** 2015-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308944, "Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01308944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*